The global cutaneous T-cell lymphoma therapy landscape is undergoing rapid evolution due to developments in studies. A comprehensive range of {therapeuticapproaches are now available, covering traditional regimens such as topical drugs and phototherapy, to more cutting-edge interventions like chemotherapy. Furthermore, clinical trials are continual